Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare
Matinas Biopharma Holdings Inc. Total Liabilities 2014–2023
Matinas Biopharma Holdings Inc. annual total liabilities history from 2014 to 2023. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Matinas Biopharma Holdings Inc. total liabilities as of December 31, 2023: 5.9M, a 28.40% decrease year-over-year.
- Matinas Biopharma Holdings Inc. total liabilities for 2023 were 5.9M, a 28.40% decrease from 2022.
- Matinas Biopharma Holdings Inc. total liabilities for 2022 were 8.2M, a 7.36% decrease from 2021.
- Matinas Biopharma Holdings Inc. total liabilities for 2021 were 8.8M, a 22.05% increase from 2020.
- Matinas Biopharma Holdings Inc. total liabilities for 2020 were 7.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Matinas Biopharma Holdings Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2023 | $6 |
| 2022 | $8 |
| 2021 | $9 |
| 2020 | $7 |
| 2019 | $7 |
| 2018 | $4 |
| 2017 | $4 |
| 2016 | $3 |
| 2015 | $2 |
| 2014 | $1 |
Matinas Biopharma Holdings Inc. Total Liabilities — FAQ
Matinas Biopharma Holdings Inc. (MTNB) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MTNB's total liabilities history?
The chart and table above show Matinas Biopharma Holdings Inc.'s total liabilities by year and by quarter, including the growth rate.